Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gam1 and the SUMO pathway.

Roberto Boggio1, Susanna Chiocca

  • 1Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.

Cell Cycle (Georgetown, Tex.)
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NSD2 upregulation is driven by high-risk HPV E6/E7 and disrupts epithelial differentiation in HPV-associated head and neck cancer.

Journal of experimental & clinical cancer research : CR·2026
Same author

Quantifying TERT promoter mutations in tumor-derived DNA shed into the oral cavity as a potential biomarker for oral squamous cell carcinoma.

Frontiers in oncology·2026
Same author

Corrigendum to "Tongue tumor and prognostic factors: Could a diagnostic procedure influence patient outcomes?" [Oral Oncol. 165 (2025) 107298].

Oral oncology·2025
Same author

HPV-mediated PARP1 regulation and drug sensitization in head and neck cancer.

Oral oncology·2025
Same author

Tongue tumor and prognostic factors: Could a diagnostic procedure influence patient outcomes?

Oral oncology·2025
Same author

The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition.

eLife·2025
Same journal

Circular RNA circ_0001829 attenuates G2/M arrest to promote hepatocyte proliferation by sponging miR-3095-3p following liver injury.

Cell cycle (Georgetown, Tex.)·2026
Same journal

Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

BMSCs-derived exosomal miR-196a-5p promotes macrophage M2 polarization and osteogenesis in postmenopausal osteoporosis through regulating Rspo2/Wnt/β-catenin signaling.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MicroRNA-6833-3p drives prostate cancer progression and stemness by targeting the NUMB-mediated NOTCH signaling pathway.

Cell cycle (Georgetown, Tex.)·2026
Same journal

OTUD5 promotes AML progression by stabilizing SLC7A11 to suppress ferroptosis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MITF-Driven melanoma plasticity as a core mechanism of therapy resistance: integrating microenvironmental signaling, mechanotransduction, and metabolic reprogramming.

Cell cycle (Georgetown, Tex.)·2026
See all related articles

Adenoviral protein Gam1 disrupts host sumoylation by inhibiting the SUMO-activating enzyme E1. This viral strategy impacts cellular processes and highlights multifunctional viral proteins targeting host pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Virology

Background:

  • Post-translational modifications (PTMs) rapidly alter protein function, crucial for cellular processes.
  • Sumoylation, a PTM, involves enzymatic cascades attaching SUMO proteins to targets.
  • Regulation and biological roles of sumoylation remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of adenoviral protein Gam1 on the host sumoylation pathway.
  • To elucidate the mechanism by which Gam1 affects sumoylation.
  • To understand viral strategies for manipulating host cell biochemistry.

Main Methods:

  • Studying adenoviral protein Gam1.
  • Analyzing Gam1's interaction with the SUMO pathway components.

Related Experiment Videos

  • Assessing the effect of Gam1 on SUMO-activating enzyme E1 (SAE1/SAE2) activity.
  • Monitoring SUMO-unmodified substrates.

    • Main Results:

    • Adenoviral protein Gam1 inhibits the SUMO pathway.
    • Gam1 interferes with the activity of the SUMO-activating enzyme E1 (SAE1/SAE2) heterodimer.
    • This inhibition leads to the accumulation of SUMO-unmodified substrates.
    • Gam1 demonstrates multifunctional roles beyond transcriptional activation.

    Conclusions:

    • Viral protein Gam1 actively disrupts host cell sumoylation.
    • Viruses can employ multifunctional proteins to target essential host biochemical pathways.
    • This study provides a clear example of viral infection impacting host sumoylation.